In this task, you are given text for US Congressional and California state bills, your task is to generate a summary for this bill.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Preservation of Antibiotics for
Medical Treatment Act of 2011''.

SEC. 2. FINDINGS.

The Congress finds the following:
(1) In January 2001, a Federal interagency task force--
(A) released an action plan to address the
continuing decline in effectiveness of antibiotics
against common bacterial infections, referred to as
antibiotic resistance;
(B) determined that antibiotic resistance is a
growing menace to all people and poses a serious threat
to public health; and
(C) cautioned that if current trends continue,
treatments for common infections will become
increasingly limited and expensive, and, in some cases,
nonexistent.
(2) Antibiotic resistance, resulting in a reduced number of
effective antibiotics, may significantly impair the ability of
the United States to respond to terrorist attacks involving
bacterial infections or a large influx of hospitalized
patients.
(3)(A) Any overuse or misuse of antibiotics contributes to
the spread of antibiotic resistance, whether in human medicine
or in agriculture.
(B) Recognizing the public health threat caused by
antibiotic resistance, Congress took several steps to curb
antibiotic overuse in human medicine through amendments to the
Public Health Service Act (42 U.S.C. 201 et seq.) made by
section 102 of the Public Health Threats and Emergencies Act
(Public Law 106-505, title I; 114 Stat. 2315), but has not yet
addressed antibiotic overuse in agriculture.
(4) In a March 2003 report, the National Academy of
Sciences stated that--
(A) a decrease in antimicrobial use in human
medicine alone will have little effect on the current
situation; and
(B) substantial efforts must be made to decrease
inappropriate overuse in animals and agriculture.
(5) In 2010, the FDA determined that--
(A) 13.1 million kilograms of antibacterial drugs
were sold for use on food animals in the United States
in 2009;
(B) 3.3 million kilograms of antibacterial drugs
were used for human health in 2009; and
(C) therefore, 80 percent of antibacterial drugs
disseminated in the United States in 2009 were sold for
use on food animals, rather than being used for human
health.
(6)(A) Large-scale, voluntary surveys by the Department of
Agriculture's Animal and Plant Health Inspection Service in
1999, 2001, and 2006 revealed that--
(i) 84 percent of grower-finisher swine farms, 83
percent of cattle feedlots, and 84 percent of sheep
farms administer antimicrobials in the feed or water
for health or growth promotion reasons; and
(ii) many of the antimicrobials identified are
identical or closely related to drugs used in human
medicine, including tetracyclines, macrolides,
Bacitracin, penicillins, and sulfonamides; and
(B) these drugs are used in people to treat serious
diseases such as pneumonia, scarlet fever, rheumatic fever,
venereal disease, skin infections, and even pandemics like
malaria and plague, as well as bioterrorism agents like
smallpox and anthrax.
(7) Many scientific studies confirm that the nontherapeutic
use of antibiotics in agricultural animals contributes to the
development of antibiotic-resistant bacterial infections in
people.
(8) The periodical entitled ''Clinical Infectious
Diseases'' published a report in June 2002, that--
(A) was based on a 2-year review by experts in
human and veterinary medicine, public health,
microbiology, biostatistics, and risk analysis, of more
than 500 scientific studies on the human health impacts
of antimicrobial use in agriculture; and
(B) recommended that antimicrobial agents should no
longer be used in agriculture in the absence of
disease, but should be limited to therapy for diseased
individual animals and prophylaxis when disease is
documented in a herd or flock.
(9) The United States Geological Survey reported in March
2002 that--
(A) antibiotics were present in 48 percent of the
streams tested nationwide; and
(B) almost half of the tested streams were
downstream from agricultural operations.
(10) An April 1999 study by the General Accounting Office
concluded that resistant strains of 3 microorganisms that cause
food-borne illness or disease in humans (Salmonella,
Campylobacter, and E. coli) are linked to the use of
antibiotics in animals.
(11) Epidemiological research has shown that resistant
Salmonella and Campylobacter infections are associated with
increased numbers of ill patients and bloodstream infections,
and increased death.
(12) In 2010, the peer-reviewed journal Molecular Cell
published a study demonstrating that low-dosage use of
antibiotics causes a dramatic increase in genetic mutation,
raising new concerns about the agricultural practice of using
low-dosage antibiotics in order to stimulate growth promotion
and routinely prevent disease in unhealthy conditions.
(13)(A) In January 2003, Consumer Reports published test
results on poultry products bought in grocery stores nationwide
showing disturbingly high levels of Campylobacter and
Salmonella bacteria that were resistant to the antibiotics used
to treat food-borne illnesses.
(B) The Food and Drug Administration's National
Antimicrobial Resistance Monitoring System routinely finds that
retail meat products are contaminated with bacteria (including
the foodborne pathogens Campylobacter and Salmonella) that are
resistant to antibiotics important in human medicine.
(C) In December 2007, the USDA issued a fact sheet on the
recently recognized link between antimicrobial drug use in
animals and Methicillin Resistant Staphylococcus Aureas (MRSA)
infections in humans.
(14) In October 2001, the New England Journal of Medicine
published an editorial urging a ban on nontherapeutic use of
medically important antibiotics in animals.
(15)(A) In 1998, the National Academy of Sciences noted
that antibiotic-resistant bacteria generate a minimum of
$4,000,000,000 to $5,000,000,000 in costs to United States
society and individuals yearly.
(B) In 2009, Cook County Hospital and the Alliance for
Prudent Use of Antibiotics estimated that the total health care
cost of antibiotic resistant infections in the United States
was between $16,600,000,000 and $26,000,000,000 annually.
(16) The American Medical Association, the American Public
Health Association, the National Association of County and City
Health Officials, and the National Campaign for Sustainable
Agriculture are among the more than 300 organizations
representing health, consumer, agricultural, environmental,
humane, and other interests that have supported enactment of
legislation to phase out nontherapeutic use in farm animals of
medically important antibiotics.
(17) In 2010, the Danish Veterinary and Food Administration
testified that the Danish ban of the non-therapeutic use of
antibiotics in food animal production resulted in a marked
reduction in antimicrobial resistance in multiple bacterial
species, including Campylobacter and Enterococci.
(18) In 2009, the Congressional Research Service concluded
that restrictions overseas on the use of antimicrobial drugs in
the production of livestock could impact U.S. export markets
for livestock and poultry.
(19) The Federal Food, Drug, and Cosmetic Act (21 U.S.C.
301 et seq.)--
(A) requires that all drugs be shown to be safe
before the drugs are approved; and
(B) places the burden on manufacturers to account
for health consequences and prove safety.
(20)(A) The Food and Drug Administration recently modified
the drug approval process for antibiotics to recognize the
development of resistant bacteria as an important aspect of
safety, but most antibiotics currently used in animal
production systems for nontherapeutic purposes were approved
before the Food and Drug Administration began considering
resistance during the drug-approval process.
(B) The Food and Drug Administration has not established a
schedule for reviewing those existing approvals.
(21) Certain non-routine uses of antibiotics in animal
agriculture are legitimate to prevent animal disease.
(22) An April 2004 study by the General Accounting Office--
(A) concluded that Federal agencies do not collect
the critical data on antibiotic use in animals that
they need to support research on human health risks;
and
(B) recommends that the Department of Agriculture
and the Department of Health and Human Services develop
and implement a plan to collect data on antibiotic use
in animals.

SEC. 3. PURPOSE.

The purpose of this Act is to preserve the effectiveness of
medically important antibiotics used in the treatment of human and
animal diseases by reviewing the safety of certain antibiotics for
nontherapeutic purposes in food-producing animals.

SEC. 4. PROOF OF SAFETY OF CRITICAL ANTIMICROBIAL ANIMAL DRUGS.

(a) Definitions.--Section 201 of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 321) is amended by adding at the end the
following:
''(ss) Critical Antimicrobial Animal Drug.--The term 'critical
antimicrobial animal drug' means a drug that--
''(1) is intended for use in food-producing animals; and
''(2) is composed wholly or partly of--
''(A) any kind of penicillin, tetracycline,
macrolide, lincosamide, streptogramin, aminoglycoside,
or sulfonamide; or
''(B) any other drug or derivative of a drug that
is used in humans or intended for use in humans to
treat or prevent disease or infection caused by
microorganisms.
''(tt) Nontherapeutic Use.--The term 'nontherapeutic use', with
respect to a critical antimicrobial animal drug, means any use of the
drug as a feed or water additive for an animal in the absence of any
clinical sign of disease in the animal for growth promotion, feed
efficiency, weight gain, routine disease prevention, or other routine
purpose.''.
(b) Applications Pending or Submitted After Enactment.--Section
512(d)(1) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360b(d)(1)) is amended--
(1) in the first sentence--
(A) in subparagraph (H), by striking ''or'' at the
end;
(B) in subparagraph (I), by inserting ''or'' at the
end; and
(C) by inserting after subparagraph (I) the
following:
''(J) with respect to a critical antimicrobial
animal drug or a drug of the same chemical class as a
critical antimicrobial animal drug, the applicant has
failed to demonstrate that there is a reasonable
certainty of no harm to human health due to the
development of antimicrobial resistance that is
attributable, in whole or in part, to the
nontherapeutic use of the drug; or''; and
(2) in the second sentence, by striking ''(A) through (I)''
and inserting ''(A) through (J)''.
(c) Phased Elimination of Nontherapeutic Use in Animals of Critical
Antimicrobial Animal Drugs Important for Human Health.--Section 512 of
the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b) is amended by
adding at the end the following:
''(q) Phased Elimination of Nontherapeutic Use in Animals of
Critical Antimicrobial Animal Drugs Important for Human Health.--
''(1) Applicability.--This subsection applies to the
nontherapeutic use in a food-producing animal of a drug--
''(A)(i) that is a critical antimicrobial animal
drug; or
''(ii) that is of the same chemical class as a
critical antimicrobial animal drug; and
''(B)(i) for which there is in effect an approval
of an application or an exemption under subsection (b),
(i), or (j) of section 505; or
''(ii) that is otherwise marketed for use.
''(2) Withdrawal.--The Secretary shall withdraw the
approval of a nontherapeutic use in food-producing animals
described in paragraph (1) on the date that is 2 years after
the date of enactment of this subsection unless--
''(A) before the date that is 2 years after the
date of the enactment of this subsection, the Secretary
makes a final written determination that the holder of
the approved application has demonstrated that there is
a reasonable certainty of no harm to human health due
to the development of antimicrobial resistance that is
attributable in whole or in part to the nontherapeutic
use of the drug; or
''(B) before the date specified in subparagraph
(A), the Secretary makes a final written determination
under this subsection, with respect to a risk analysis
of the drug conducted by the Secretary and other
relevant information, that there is a reasonable
certainty of no harm to human health due to the
development of antimicrobial resistance that is
attributable in whole or in part to the nontherapeutic
use of the drug.
''(3) Exemptions.--Except as provided in paragraph (5), if
the Secretary grants an exemption under section 505(i) for a
drug that is a critical antimicrobial animal drug, the
Secretary shall rescind each approval of a nontherapeutic use
in a food-producing animal of the critical antimicrobial animal
drug, or of a drug in the same chemical class as the critical
antimicrobial animal drug, as of the date that is 2 years after
the date on which the Secretary grants the exemption.
''(4) Approvals.--Except as provided in paragraph (5), if
an application for a drug that is a critical antimicrobial
animal drug is submitted to the Secretary under section 505(b),
the Secretary shall rescind each approval of a nontherapeutic
use in a food-producing animal of the critical antimicrobial
animal drug, or of a drug in the same chemical class as the
critical antimicrobial animal drug, as of the date that is 2
years after the date on which the application is submitted to
the Secretary.
''(5) Exception.--Paragraph (3) or (4), as the case may be,
shall not apply if--
''(A) before the date on which approval would be
rescinded under that paragraph, the Secretary makes a
final written determination that the holder of the
application for the approved nontherapeutic use has
demonstrated that there is a reasonable certainty of no
harm to human health due to the development of
antimicrobial resistance that is attributable in whole
or in part to the nontherapeutic use in the food-
producing animal of the critical antimicrobial animal
drug; or
''(B) before the date specified in subparagraph
(A), the Secretary makes a final written determination
under this subsection, with respect to a risk analysis
of the critical antimicrobial animal drug conducted by
the Secretary and any other relevant information, that
there is a reasonable certainty of no harm to human
health due to the development of antimicrobial
resistance that is attributable in whole or in part to
the nontherapeutic use of the drug.''.

SEC. 5. COMMITTEE HEARINGS ON IMPLEMENTATION.

(a) In General.--The Committee on Energy and Commerce of the House
of Representatives and the Committee on Energy of the Senate shall each
hold a hearing on the implementation by the Commissioner of Food and
Drugs of section 512(q) of the Federal Food, Drug, and Cosmetic Act, as
added by section 4 of this Act.
(b) Exercise of Rulemaking Authority.--Subsection (a) is enacted--
(1) as an exercise of the rulemaking power of the House of
Representatives and Senate, and, as such, they shall be
considered as part of the rules of the House or Senate (as the
case may be), and such rules shall supersede any other rule of
the House or Senate only to the extent that rule is
inconsistent therewith; and
(2) with full recognition of the constitutional right of
either House to change such rules (so far as relating to the
procedure in such House) at any time, in the same manner, and
to the same extent as in the case of any other rule of the
House or Senate.
Example Output: Preservation of Antibiotics for Medical Treatment Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services (HHS) to deny an application for a new animal drug that is a critical antimicrobial animal drug unless the applicant demonstrates that there is a reasonably certainty of no harm to human health due to the development of antimicrobial resistance attributable to the nontherapeutic use of the drug. Defines "critical antimicrobial animal drug" as a drug intended for use in food-producing animals that contains specified antibiotics or other drugs used in humans to treat or prevent disease or infection caused by microorganisms.

Requires the Secretary to withdraw approval of a nontherapeutic use of such drugs in food-producing animals two years after the date of enactment of this Act unless certain safety requirements are met. Directs specified congressional committees to hold hearings on the implementation of such a withdrawal of approval.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Medicare Home Health Rebasing Relief
and Reassessment Act''.

SEC. 2. RELIEF AND REASSESSMENT OF THE REBASING OF MEDICARE HOME HEALTH
PROSPECTIVE PAYMENT AMOUNTS.

(a) Suspension of Rebasing.--Section 1895(b)(3)(A)(iii) of the
Social Security Act (42 U.S.C. 1395fff(b)(3)(A)(iii)) is amended--
(1) in subclause (I), in the first sentence, by striking
''subclause (II)'' and inserting ''subclauses (II) and (III)'';
(2) in subclause (II), in the first sentence, by striking
''The Secretary'' and inserting ''Subject to subclause (III),
the Secretary''; and
(3) by adding at the end the following new subclause:
''(III) Special rule.--Subclauses
(I) and (II) shall not apply for the
12-month period beginning on the date
of the enactment of this subclause. For
periods beginning after the period
described in the previous sentence, the
Secretary shall apply such subclauses
as if the previous sentence had not
been enacted.''.
(b) Revision of Home Health Outlier Adjustment.--Section
1895(b)(5)(A) of the Social Security Act (42 U.S.C. 1395fff(b)(5)(A))
is amended, in the second sentence, by inserting ''(or, in the case of
each of the years 2015 through 2023, 2.25 percent)'' after ''2.5
percent''.
(c) Study and Report.--
(1) Study.--
(A) In general.--The Secretary of Health and Human
Services, in consultation with representatives of
Medicare home health agencies and beneficiaries, shall
conduct a study on alternative methods for determining
the appropriate adjustment under section
1895(b)(3)(A)(iii) of the Social Security Act (42
U.S.C. 1395(b)(3)(A)(iii)), including methods offered
by stakeholders. Such study shall include an analysis
of each of the following:
(i) The projected impact on Medicare
beneficiary access to care during each of 2014
through 2017 of applying section 1895(b)(3)
during each of such years without application
of subparagraph (A)(iii) of such section,
compared to the projected impact on such access
during each of such years of applying such
section during each of such years with
application of such subparagraph.
(ii) The number and share of home health
agencies that are projected to experience
negative Medicare margins by 2017, including
the location, size, and type of such agencies.
(iii) With respect to home health agencies
described in clause (ii)--
(I) the total number, average age,
average income, and average number of
activities of daily living of the
Medicare beneficiaries such agencies
serve;
(II) the number of staff such
agencies employ;
(III) the number and location of
counties in which such agencies serve
as the sole provider of Medicare home
health services; and
(IV) to the extent practicable, the
payer mix of such agencies.
(iv) The impact of the adjustment on small
home health agencies, as defined by the United
States Small Business Administration small
business size standards, consistent with the
principles of the Regulatory Flexibility Act,
which requires Federal agencies, including the
Department of Health and Human Services, to
fully consider during the rulemaking process
the economic impact of regulatory provisions,
as well as less burdensome regulatory
alternatives, to small entities.
(v) Any other areas determined appropriate
by the Secretary.
(B) Requirement for alternative methods and other
considerations.--For purposes of the analysis under
subparagraph (A)--
(i) the alternative methods described in
such subparagraph shall cover each of the years
in which the rebasing adjustment under such
section 1895(b)(3)(A)(iii) is to be applied;
and
(ii) the Secretary shall include a
cumulative analysis of other Medicare home
health reimbursement reductions established by
statute or regulation, consistent with the
requirements of Executive Order 13563.
(2) Report.--Not later than 6 months after the date of the
enactment of this Act, the Secretary of Health and Human
Services shall submit to Congress a report on the study
conducted under paragraph (1), together with such
recommendations as the Secretary determines appropriate based
on the findings of such study. Such report shall include--
(A) a determination by the Secretary as to whether,
as a result of the findings of such study, the
Secretary intends to use the authority under section
1871 of the Social Security Act (42 U.S.C. 1395hh) to
modify the adjustment described in paragraph (1)(A) and
the extent of any such modification; and
(B) in the case the Secretary determines not to use
such authority, the rationale for such determination.
Example Output: Medicare Home Health Rebasing Relief and Reassessment Act - Amends title XVIII (Medicare) of the Social Security Act, with respect to the system for prospective payments for home health services, to suspend for a 12-month period a specified adjustment to (rebasing of) Medicare home health prospective payment amounts. Revises the home health outlier adjustment to equal not to exceed 2.25% (currently, 2.5%) for 2015 through 2023. Directs the Secretary of Health and Human Services (HHS) to study alternative methods for determining the appropriate adjustment for 2014 and subsequent years to the prospective payment for home health services, including methods offered by stakeholders.

Example Input: SECTION 1. SHORT TITLE.

This Act may be cited as the ''Rural Mental Health Accessibility
Act of 2001''.

SEC. 2. AMENDMENT TO THE PUBLIC HEALTH SERVICE ACT.

Subpart I of part D of title III of the Public Health Service Act
(42 U.S.C. 254b et seq.) is amended by adding at the end the following:

''SEC. 330I. MENTAL HEALTH COMMUNITY EDUCATION PROGRAM.

''(a) Program Authorized.--The Director of the Office of Rural
Health Policy (of the Health Resources and Services Administration)
shall award grants to eligible entities to conduct mental health
community education programs.
''(b) Definitions.--In this section:
''(1) Eligible entity.--The term 'eligible entity' includes
a State entity, public or private school, mental health clinic,
rural health clinic, local public health department, nonprofit
private entity, federally qualified health center, Rural Area
Health Education Center, Indian tribe and tribal organization,
and any other entity deemed eligible by the Secretary.
''(2) Mental health community education program.--The term
'mental health community education program' means a program
regarding mental illness, mental retardation, suicide
prevention and co-occurring mental illness and substance abuse
disorder.
''(c) Preference.--In awarding grants under subsection (a), the
Director shall give a preference to eligible entities that are or
propose to be in a network, or work in collaboration, with other
eligible entities to carry out the programs under this section, such as
a rural public or nonprofit private entity that represents a network of
local health care providers or other entities that provide or support
delivery of health care services, and a State office of rural health or
other appropriate State entity.
''(d) Duration.--The Director shall award grants under subsection
(a) for a period of 3 years.
''(e) Amount.--Each grant awarded under this section shall not be
greater than $200,000 each fiscal year.
''(f) Use of Funds.--An eligible entity that receives a grant under
subsection (a) shall use funds received through such grant to
administer a mental health community education program to rural
populations that provides information to dispel myths regarding mental
illness and to reduce any stigma associated with mental illness.
''(g) Application.--An eligible entity desiring a grant under
subsection (a) shall submit an application to the Director at such
time, in such manner, and containing such information as the Director
may reasonably require, including--
''(1) a description of the activities which the eligible
entity intends to carry out using amounts provided under the
grant;
''(2) a plan for continuing the project after Federal
support is ended;
''(3) a description of the manner in which the educational
activities funded under the grant will meet the mental health
care needs of underserved rural populations within the State;
and
''(4) a description of how the local community or region to
be served by the network or proposed network, if the eligible
entity is in such a network, will be involved in the
development and ongoing operations of the network.
''(h) Evaluations; Report.--Each eligible entity that receives a
grant under this section shall submit to the Director of the Office of
Rural Health Policy (of the Health Resources and Services
Administration) an evaluation describing the programs authorized under
this section and any other information that the Director deems
appropriate. After receiving such evaluations, the Director shall
submit to the appropriate committees of Congress a report describing
such evaluations.
''(i) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section, $50,000,000 for fiscal year
2002, and such sums as may be necessary for fiscal years 2003 through
2006.

''SEC. 330J. INTERDISCIPLINARY GRANT PROGRAM.

''(a) Program Authorized.--The Director of the Office of Rural
Health Policy (of the Health Resources and Services Administration)
shall award grants to eligible entities to establish interdisciplinary
training programs that include significant mental health training in
rural areas for certain health care providers.
''(b) Definitions.--In this section:
''(1) Eligible entity.--The term 'eligible entity' means a
public university or other educational institution that
provides training for mental health care providers or primary
health care providers.
''(2) Mental health care provider.--The term 'mental health
care provider' means--
''(A) a physician with postgraduate training in a
residency program of psychiatry;
''(B) a licensed psychologist (as defined by the
Secretary for purposes of section 1861(ii) of such Act
(42 U.S.C. 1395x(ii)));
''(C) a clinical social worker (as defined in
section 1861(hh)(1) of such Act (42 U.S.C.
1395x(hh)(1)); or
''(D) a clinical nurse specialist (as defined in
section 1861(aa)(5)(B) of such Act (42 U.S.C.
1395x(aa)(5)(B))).
''(3) Primary health care provider.--The term 'primary
health care provider' includes family practice, internal
medicine, pediatrics, obstetrics and gynecology, geriatrics,
and emergency medicine physicians as well as physician
assistants and nurse practitioners.
''(4) Rural area.--The term 'rural area' means a rural area
as defined in section 1886(d)(2)(D) of the Social Security Act,
or such an area in a rural census tract of a metropolitan
statistical area (as determined under the most recent
modification of the Goldsmith Modification, originally
published in the Federal Register on February 27, 1992 (57 Fed.
Reg. 6725)), or any other geographical area that the Director
designates as a rural area.
''(c) Duration.--Grants awarded under subsection (a) shall be
awarded for a period of 5 years.
''(d) Use of Funds.--An eligible entity that receives a grant under
subsection (a) shall use funds received through such grant to
administer an interdisciplinary, side-by-side training program for
mental health care providers and primary health care providers, that
includes providing, under appropriate supervision, health care services
to patients in underserved, rural areas without regard to patients'
ability to pay for such services.
''(e) Application.--An eligible entity desiring a grant under
subsection (a) shall submit an application to the Director at such
time, in such manner, and containing such information as the Director
may reasonably require, including--
''(1) a description of the activities which the eligible
entity intends to carry out using amounts provided under the
grant;
''(2) a description of the manner in which the activities
funded under the grant will meet the mental health care needs
of underserved rural populations within the State; and
''(3) a description of the network agreement with
partnering facilities.
''(f) Evaluations; Report.--Each eligible entity that receives a
grant under this section shall submit to the Director of the Office of
Rural Health Policy (of the Health Resources and Services
Administration) an evaluation describing the programs authorized under
this section and any other information that the Director deems
appropriate. After receiving such evaluations, the Director shall
submit to the appropriate committees of Congress a report describing
such evaluations.
''(g) Authorization of Appropriations.--There is authorized to be
appropriated to carry out this section, $100,000,000 for fiscal year
2002 and such sums as may be necessary for each of the fiscal years
2003 through 2006.

''SEC. 330K. STUDY OF MENTAL HEALTH SERVICES DELIVERED WITH TELEHEALTH
TECHNOLOGIES.

''(a) In General.--The Director of the National Institute of Mental
Health, in consultation with the Director of the Office of Rural Health
Policy, shall carry out activities to research the efficacy and
effectiveness of mental health services delivered remotely by a
qualified mental health professional (psychiatrist or doctoral level
psychologist) using telehealth technologies.
''(b) Mandatory Activities.--Research described in subsection (a)
shall include--
''(1) objective measurement of treatment outcomes for
individuals with mental illness treated remotely using
telehealth technologies as compared to individuals with mental
illness treated face-to-face;
''(2) objective measurement of treatment compliance by
individuals with mental illness treated remotely using
telehealth technologies as compared to individuals with mental
illness treated face-to-face; and
''(3) any other variables as determined by the Director.
''(c) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section such sums as may be necessary.

''SEC. 330L. MENTAL HEALTH SERVICES DELIVERED VIA TELEHEALTH.

''(a) Program Authorized.--
''(1) In general.--The Secretary, acting through the
Director of the Office for the Advancement of Telehealth of the
Health Resources and Services Administration, shall award
grants to eligible entities to establish demonstration projects
for the provision of mental health services to special
populations as delivered remotely by qualified mental health
professionals using telehealth and for the provision of
education regarding mental illness as delivered remotely by
qualified mental health professionals and qualified mental
health education professionals using telehealth.
''(2) Number of demonstration projects.--Ten grants shall
be awarded under paragraph (1) to provide services for the
children and adolescents described in subsection (d)(1)(A) and
not less than 6 of such grants shall be for services rendered
to individuals in rural areas. Ten grants shall also be awarded
under paragraph (1) to provide services for the elderly
described in subsection (d)(1)(B) in rural areas. If the
maximum number of grants to be awarded under paragraph (1) is
not awarded, the Secretary shall award the remaining grants in
a manner that is equitably distributed between the populations
described in subparagraphs (A) and (B) of subsection (d)(1).
''(b) Definitions.--In this section:
''(1) Eligible entity.--The term 'eligible entity' means a
public or nonprofit private telehealth provider network which
has as part of its services mental health services provided by
qualified mental health providers.
''(2) Qualified mental health education professionals.--The
term 'qualified mental health education professionals' refers
to teachers, community mental health professionals, nurses, and
other entities as determined by the Secretary who have
additional training in the delivery of information on mental
illness to children and adolescents or who have additional
training in the delivery of information on mental illness to the
elderly.
''(3) Qualified mental health professionals.--The term
'qualified mental health professionals' refers to providers of
mental health services currently reimbursed under medicare who
have additional training in the treatment of mental illness in
children and adolescents or who have additional training in the
treatment of mental illness in the elderly.
''(4) Special populations.--The term 'special populations'
refers to the following 2 distinct groups:
''(A) Children and adolescents located in primary
and secondary public schools in mental health
underserved rural areas or in mental health underserved
urban areas.
''(B) Elderly individuals located in long-term care
facilities in mental health underserved rural areas.
''(5) Telehealth.--The term 'telehealth' means the use of
electronic information and telecommunications technologies to
support long-distance clinical health care, patient and
professional health-related education, public health, and
health administration.
''(c) Amount.--Each entity that receives a grant under subsection
(a) shall receive not less than $1,500,000 with no more than 40 percent
of the total budget outlined for equipment.
''(d) Use of Funds.--
''(1) In general.--An eligible entity that receives a grant
under this section shall use such funds--
''(A) for the populations described in subsection
(b)(3)(A)--
''(i) to provide mental health services,
including diagnosis and treatment of mental
illness, in primary and secondary public
schools as delivered remotely by qualified
mental health professionals using telehealth;
''(ii) to provide education regarding
mental illness (including suicide and violence)
in primary and secondary public schools as
delivered remotely by qualified mental health
professionals and qualified mental health
education professionals using telehealth,
including early recognition of the signs and
symptoms of mental illness, and instruction on
coping and dealing with stressful experiences
of childhood and adolescence (such as violence,
social isolation, and depression); and
''(iii) to collaborate with local public
health entities and the eligible entity to
provide the mental health services; and
''(B) for the populations described in subsection
(b)(3)(B)--
''(i) to provide mental health services,
including diagnosis and treatment of mental
illness, in long-term care facilities as
delivered remotely by qualified mental health
professionals using telehealth;
''(ii) to provide education regarding
mental illness to primary staff (including
physicians, nurses, and nursing aides) as
delivered remotely by qualified mental health
professionals and qualified mental health
education professionals using telehealth,
including early recognition of the signs and
symptoms of mental illness, and instruction on
coping and dealing with stressful experiences
of old age (such as loss of physical and
cognitive capabilities, death of loved ones and
friends, social isolation, and depression); and
''(iii) to collaborate with local public
health entities and the eligible entity to
provide mental health services.
''(2) Other uses.--An eligible entity receiving a grant
under this section may also use funds to--
''(A) acquire telehealth equipment to use in
primary and secondary public schools and long-term care
facilities for the purposes of this section;
''(B) develop curriculum to support activities
described in subsections (d)(1)(A)(ii) and
(d)(1)(B)(ii);
''(C) pay telecommunications costs; and
''(D) pay qualified mental health professionals and
qualified mental health education professionals on a
reasonable cost basis as determined by the Secretary
for services rendered.
''(3) Prohibited uses.--An eligible entity that receives a
grant under this section shall not use funds received through
such grant to--
''(A) purchase or install transmission equipment
(other than such equipment used by qualified mental
health professionals to deliver mental health services
using telehealth under the project); or
''(B) build upon or acquire real property (except
for minor renovations related to the installation of
reimbursable equipment).
''(e) Equitable Distribution.--In awarding grants under this
section, the Secretary shall ensure, to the greatest extent possible,
that such grants are equitably distributed among geographical regions
of the United States.
''(f) Application.--An entity that desires a grant under this
section shall submit an application to the Secretary at such time, in
such manner, and containing such information as the Secretary
determines to be reasonable.
''(g) Report.--Not later than 5 years after the date of enactment
of this section, the Secretary shall prepare and submit a report to the
appropriate committees of Congress that shall evaluate activities
funded with grants under this section.
''(h) Authorization of Appropriations.--There are authorized to be
appropriated to carry out this section, $30,000,000 for fiscal year
2002 and such sums that are required to carry out this program for
fiscal years 2003 through 2009.
''(i) Sunset Provision.--This section shall be effective for 7
years from the date of enactment of this section.''.
Example Output:
Rural Mental Health Accessibility Act of 2001 - Amends the Public Health Service Act to direct the Director of the Office of Rural Health Policy to: (1) award grants to eligible entities to conduct mental health community education programs; (2) award grants to eligible entities to establish interdisciplinary training programs that include significant mental health training in rural areas for certain health care providers.Directs the Director of the National Institute of Mental Health to carry out activities to research the efficacy and effectiveness of mental health services delivered remotely by a qualified mental health professional (psychiatrist or doctoral level psychologist) using telehealth technologies.Directs the Secretary of Health and Human Services to award grants to eligible entities to establish demonstration projects for the provision of mental health services to special populations as delivered remotely by qualified mental health professionals using telehealth and for the provision of education regarding mental illness as delivered remotely by qualified mental health professionals and qualified mental health education professionals using telehealth.Authorizes appropriations.